Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Cancer ; 21(1): 229, 2021 Mar 06.
Article in English | MEDLINE | ID: mdl-33676446

ABSTRACT

BACKGROUND: A recent study found an influence of organized mammography screening programmes (MSPs) on geographical and temporal variation of mastectomy rates. We aimed to quantify the effect on the example of one of the cantonal programmes in Switzerland. METHODS: We used incidence data for the years 2010-2017 from the cancer registry of Eastern Switzerland. We included women with invasive-non-metastatic breast cancer (BC) in the screening age group 50-69-year-olds in the canton of St.Gallen. We compared mastectomy rates among cancer patients detected through the organised screening programme (MSP) vs. otherwise detected by stage. RESULTS: MSP-detected patients in St.Gallen presented with lower stages. 95% of MSP-detected had stages I-II vs 76% of Non-MSP-detected. Within all non-metastatic stage, tumour size and nodal status groups, MSP-detected patients had lower mastectomy rates, overall 10% vs 24% in 50-69-year-old non-participants. Their odds of receiving a mastectomy are about half of the Non-MSP-detected (OR = 0.48, p = 0.002). CONCLUSIONS: Our study showed that MSPs have a positive effect on lowering mastectomy rates. Screening participants are significantly less likely to receive a mastectomy compared to non-participants, which must be attributed to additional factors than just lower stages. Lower mastectomy rates lead to a higher quality of life for many patients.


Subject(s)
Breast Neoplasms/surgery , Early Detection of Cancer/statistics & numerical data , Mammography/statistics & numerical data , Mass Screening/organization & administration , Mastectomy/statistics & numerical data , Aged , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Female , Geography , Humans , Incidence , Mass Screening/statistics & numerical data , Mastectomy/adverse effects , Middle Aged , Neoplasm Staging , Program Evaluation , Quality of Life , Registries/statistics & numerical data , Switzerland/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...